Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.10.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Restricted cash $ 53,726 $ 46,012
Notes receivable, net $ 439,167 $ 426,858
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 74,445,923 74,734,455
Common stock, shares outstanding 74,445,923 74,734,455
Variable Interest Entity, Primary Beneficiary [Member]    
Restricted cash $ 28,400 $ 19,488
Notes receivable, net $ 341,975 $ 279,188